longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

biote Corp.

BTMD

1.2553.46% ( -0.045 )
Trading: Sep 24, 14:15:20 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 7.98, within the reasonable range, cheaper than 56.83% of the time in the past 3 years, and the industry ranks 8/257, the industry Median -1.41.

7.98xP/E
$1.30Stock price
$0.16Earnings per share
7.98xP/E
Stock price$1.30Earnings per share$0.16

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
9.60x
Typical range
3.23x–42.93x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS
9.33x5.88%$168.82B
SGIOYUSShionogi
9.44x--$15.90B
INVAUSInnoviva
4.09x32.30%$1.46B
APMDUSApnimed
5.48x114.94%$895.62M
CRMDUSCormedix
3.22x75.74%$599.39M
ORMPUSOramed Pharma
1.13x198.00%$196.34M
OGIUSOrganigram
2.37x510.33%$147.16M
SDEVUSStablecoin Development
0.12x--$56.69M
BTMDUSbiote Corp.
7.98x127.70%$46.71M
OWPCUSOne World Products, Inc.
0.04x--$142.42K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.